Trial
NCT03492164
In Vivo PARP-1 Expression With 18F-FTT PET/CT in Pancreatic Cancer
Early Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Abramson Cancer Center at Penn Medicine
Collaborators
—
Condition
Pancreatic Cancer
Intervention
[18F]FluorThanatrace ([18F]FTT)
Why stopped
Early analysis of images after 6 patients showed no activity of the radiotracer in this patient population.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-06-12